Antipodes Partners’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$119K Buy
362
+74
+26% +$26.6K ﹤0.01% 90
2025
Q4
$101K Buy
288
+197
+216% +$71.8K ﹤0.01% 89
2025
Q3
$33.6K Buy
+91
New +$35.2K ﹤0.01% 103

Other funds holding SYK

Antipodes Partners's SYK Position: Q1 2026 in Review

Antipodes Partners increased its Stryker (SYK) stake by 26% in Q1 2026, buying an estimated $26.6K and bringing the position to 362 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #90.

Antipodes Partners first reported a position in SYK in Q3 2025 and has held it in 3 quarters since. 2,294 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Antipodes Partners held 362 shares of Stryker worth $119K as of Q1 2026.
  • Antipodes Partners bought 74 Stryker shares in Q1 2026, an estimated $26.6K.
  • Stryker made up ﹤0.01% of Antipodes Partners's portfolio in Q1 2026, its #90 holding.
  • Antipodes Partners first reported a position in Stryker in Q3 2025 and has held it in 3 quarters since.
  • 2,294 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Antipodes Partners's 13F filing for Q1 2026, filed 5 May 2026.